ghk-cu long-term use sustained benefits no tolerance Peptide Therapy for Pain Management and Healing Emerging Peptide Therapies in Orthopaedics:

How Long Does GHK-Cu Take to Work

Results from 327 women demonstrated: Significant increases in satisfying sexual events compared to placebo at 1.25 mg and 1.75 mg doses Improved Female Sexual Function Index total scores (mean improvement of 3.6 points vs 1.9 for placebo) Reduced sexual distress as measured by Female Sexual Distress Scale scores Dose-dependent response with optimal effects at 1.75 mg Two Phase 3 trials (RECONNECT studies) enrolled over 1,200 premenopausal women with acquired, generalized HSDD and confirmed efficacy at the 1.75 mg dose administered subcutaneously at least 45 minutes before anticipated sexual activity

As your treatment is underway, your physician may also periodically order additional lab tests to determine how your body is responding to the peptides

As a naturally occurring compound present in human plasma from birth, GHK-Cu has an inherent level of biological compatibility